Sharfah Ahmad Qazi | Supply Chain Management | Innovative Research Award |

Published on by Business Global Awards

Innovative Research Award

Sharfah Ahmad Qazi — University of Kassel, Germany

Sharfah Ahmad Qazi
Affiliation University of Kassel
Country Germany
Scopus ID 57807836300
Documents 4
Citations
41
h-index 2
Subject Area Supply Chain Management
Event World Business Global Awards
ORCID 0000-0003-3077-8377

Sharfah Ahmad Qazi is a researcher affiliated with the University of Kassel in Germany whose stated subject area is Supply Chain Management. The profile is associated with Scopus Author ID 57807836300 and ORCID 0000-0003-3077-8377. This article presents the available researcher information in the context of the Innovative Research Award associated with the World Business Global Awards.

Abstract

This academic recognition profile presents the available scholarly information concerning Sharfah Ahmad Qazi of the University of Kassel, Germany. The supplied profile identifies Supply Chain Management as the subject area and associates the researcher with Scopus Author ID 57807836300 and ORCID 0000-0003-3077-8377. Persistent researcher identifiers provide mechanisms for distinguishing scholarly authors and connecting their research records across academic information systems. [1] [2]

In the context of the Innovative Research Award, the profile represents research activity situated within the broad field of supply chain management. Because publication counts, citation totals, and h-index information were not included in the supplied data, this article does not assign quantitative research-impact values or make unsupported comparative claims.

Keywords

Keywords: Supply Chain Management; Supply Chain Innovation; Logistics Management; Sustainable Supply Chains; Supply Chain Resilience; Procurement; Operations Management; Digital Supply Chains; Research Innovation; Supply Chain Strategy.

Introduction

Supply Chain Management examines the planning, coordination, sourcing, production, distribution, and control of activities involved in the movement of goods, services, information, and resources across interconnected organizations. Contemporary research in the field also considers resilience, sustainability, digitalization, collaboration, risk management, and the integration of supply chain networks.

Sharfah Ahmad Qazi is identified in the supplied profile information as being affiliated with the University of Kassel and working within Supply Chain Management. The researcher is associated with Scopus Author ID 57807836300 and ORCID 0000-0003-3077-8377. [1] [2]

Research Profile

The supplied research profile places Sharfah Ahmad Qazi within Supply Chain Management. This discipline encompasses the design and management of interconnected supply networks and includes topics such as procurement, logistics, inventory management, operations coordination, supplier relationships, sustainability, resilience, and information flows.

The University of Kassel provides the institutional context identified for the researcher. Scopus and ORCID provide complementary mechanisms for scholarly identity management: Scopus maintains author records within its bibliographic database, while ORCID provides a persistent identifier intended to distinguish researchers and connect their scholarly contributions across systems. [1] [2]

The supplied information does not include a verified number of documents, citations, or h-index. These fields are therefore recorded as not specified rather than estimated from unrelated or unverified sources.

Research Contributions

Based on the stated subject area, research associated with Supply Chain Management may address a range of interconnected organizational and operational challenges. The following themes describe relevant areas of scholarly contribution without attributing specific unpublished or undocumented projects to the researcher:

  • Supply chain design and coordination across interconnected organizations and operational networks.
  • Supply chain innovation involving new management approaches, processes, business models, or network configurations.
  • Supply chain resilience and organizational responses to disruption, uncertainty, and changing operating environments.
  • Sustainable supply chain practices addressing environmental, economic, and social considerations.
  • Digitalization and data-enabled approaches to supply chain planning, coordination, visibility, and decision-making.

The themes above establish an appropriate disciplinary context for an innovation-oriented research profile but should not be interpreted as a definitive inventory of the researcher’s publications or projects without bibliographic verification.

Publications

No individual publication titles, journal records, conference papers, books, book chapters, or DOI identifiers were supplied in the input data. Accordingly, this page does not attribute particular publications to Sharfah Ahmad Qazi without independent bibliographic verification.

The Scopus Author Profile and ORCID record can be consulted to identify scholarly works associated with the supplied persistent identifiers. Bibliographic records should be checked for author identity, publication details, dates, and subject relevance before being used as evidence of a specific research contribution. [1] [2]

Research Impact

Research impact in Supply Chain Management can be examined through scholarly influence, practical implementation, methodological development, industry engagement, policy relevance, knowledge transfer, and measurable improvements arising from documented research applications. Citation indicators can provide one quantitative perspective, although they should be interpreted alongside publication context and other evidence.

For this profile, the supplied data does not specify citation totals, document counts, or h-index values. Therefore, no numerical impact assessment is presented. A complete evaluation would require a dated and verifiable bibliographic record together with evidence of the nature and significance of the research contributions.

Award Suitability

The Innovative Research Award is presented in connection with a researcher whose stated subject area is Supply Chain Management. This creates a disciplinary context in which innovation may be examined through research methods, supply chain processes, organizational practices, sustainability initiatives, resilience frameworks, digital approaches, or other documented advances relevant to the field.

A formal award assessment should be based on the applicable award criteria and independently verifiable evidence. Relevant evidence may include peer-reviewed publications, documented research contributions, innovative methodologies, applied projects, patents or intellectual-property records where applicable, industry or institutional outcomes, and other materials demonstrating the nature of the candidate’s work.

The recognition is associated with the World Business Global Awards. Information concerning the award program, submission procedures, and applicable recognition framework should be obtained from the official award website.

Conclusion

Sharfah Ahmad Qazi is identified as a researcher affiliated with the University of Kassel in Germany, with Supply Chain Management listed as the subject area. The profile is associated with Scopus Author ID 57807836300 and ORCID 0000-0003-3077-8377. These identifiers provide useful mechanisms for scholarly record discovery and author disambiguation. [1] [2]

Within the context of the Innovative Research Award, the available information establishes the researcher’s disciplinary affiliation and scholarly identifiers. Further assessment of research productivity, impact, and innovation requires additional verified publication records, quantitative indicators, and documentary evidence of specific contributions.

References

  1. Elsevier. (n.d.). Scopus author details: Sharfah Ahmad Qazi, Author ID 57807836300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57807836300
  2. ORCID. (n.d.). Sharfah Ahmad Qazi, ORCID iD 0000-0003-3077-8377. ORCID.
    https://orcid.org/0000-0003-3077-8377
  3. World Business Global Awards. (n.d.). Business Global Awards.
    https://businessglobalawards.com/
  4. Christopher, M. (2016). Logistics & Supply Chain Management (5th ed.). Pearson.
  5. Ivanov, D., & Dolgui, A. (2020). Viability of intertwined supply networks: Extending the supply chain resilience angles towards survivability. International Journal of Production Research, 58(10), 2904–2915.
    https://doi.org/10.1080/00207543.2020.1750727

NanaYang | Innovation Management | Best Innovation Award

Published on by Business Global Awards

Best Innovation Award

Nana Yang — Nanjing University of Posts and Telecommunications, China

Nana Yang
Affiliation Nanjing University of Posts and Telecommunications
Country China
Scopus ID 57215874878
Documents 10
Citations 189
h-index 7
Subject Area Innovation Management
Event World Business Global Awards
ORCID 0009-0001-6425-3432

Nana Yang is a researcher affiliated with Nanjing University of Posts and Telecommunications in China whose stated subject area is Innovation Management. The researcher is associated with Scopus Author ID 57215874878 and ORCID 0009-0001-6425-3432. This article presents the available profile information in the context of the Best Innovation Award associated with the World Business Global Awards.

Abstract

This academic recognition profile documents the available scholarly information associated with Nana Yang of Nanjing University of Posts and Telecommunications, China. The profile identifies Innovation Management as the stated subject area and records the researcher’s Scopus Author ID and ORCID identifier. These persistent identifiers provide mechanisms for distinguishing the researcher within scholarly communication and research-information systems. [1] [2]

Within the context of the Best Innovation Award, the available information supports an academic profile centered on innovation-related research. Because publication, citation, and h-index values were not supplied in the source data for this page, no quantitative research-impact claims are made beyond the documented identifiers and affiliation.

Keywords

Keywords: Innovation Management; Innovation Research; Organizational Innovation; Strategic Innovation; Research and Development; Technology Management; Business Innovation; Innovation Strategy; Academic Recognition; Research Profile.

Introduction

Innovation management is concerned with the processes through which organizations identify, develop, implement, and sustain new ideas, products, services, processes, or organizational practices. Contemporary innovation research commonly examines how knowledge, organizational capabilities, strategy, and external environments interact in the development and diffusion of innovation.

Nana Yang is identified in the supplied profile information as being affiliated with Nanjing University of Posts and Telecommunications and working within the subject area of Innovation Management. The profile is associated with Scopus Author ID 57215874878 and ORCID 0009-0001-6425-3432, allowing scholarly records to be connected to persistent researcher identifiers. [1] [2]

Research Profile

The supplied research profile places Nana Yang within Innovation Management. This field encompasses the study and practical management of innovation activities, including innovation strategy, organizational processes, knowledge development, commercialization, and the management of resources supporting innovative outcomes.

The affiliation with Nanjing University of Posts and Telecommunications provides the institutional context for the profile. The Scopus and ORCID identifiers serve different but complementary purposes in scholarly information management: Scopus provides an author identity within the Scopus research database, while ORCID provides a persistent identifier designed to distinguish researchers and connect their scholarly activities across systems. [1] [2]

The available source information does not provide a verified publication list, citation count, or h-index for inclusion in this article. Accordingly, those fields are recorded as not specified rather than estimated from external or unrelated sources.

Research Contributions

On the basis of the supplied profile information, the research context associated with Nana Yang can be described through the following Innovation Management themes:

  • Innovation management as a framework for organizing and coordinating innovation-related activities.
  • Innovation strategy and its relationship to organizational objectives and competitive development.
  • Management of knowledge and resources that support the generation and implementation of innovative ideas.
  • Organizational approaches to developing, adopting, and sustaining innovation.
  • Research-oriented examination of innovation processes within contemporary institutional and business environments.

These themes describe the academic domain represented by the supplied subject classification and should not be interpreted as a complete list of specific research projects or publications unless supported by the researcher’s bibliographic records.

Publications

No individual publication titles, journal information, conference records, or DOI identifiers were supplied for Nana Yang in the input data. Therefore, this section does not attribute specific publications to the researcher without bibliographic verification.

For authoritative publication discovery, the Scopus Author Profile and ORCID record can be consulted using the persistent identifiers provided in this article. These sources may contain bibliographic information that can be evaluated independently of the award profile. [1] [2]

Research Impact

Research impact may be examined through several forms of evidence, including scholarly publications, citation activity, collaboration, knowledge dissemination, and documented influence on research or practice. Persistent author identifiers can assist with accurate attribution when evaluating these indicators. [1] [2]

For this profile, specific citation totals, document counts, and h-index values were not included in the supplied data. Consequently, this article does not assign numerical research-impact values or make comparative claims about research performance. Any future assessment should use a dated bibliographic record and clearly identify the database and measurement period used.

Award Suitability

The Best Innovation Award is presented here in relation to a profile identified with Innovation Management. The subject-area alignment provides a relevant academic context for an innovation-focused recognition category, while the researcher’s institutional affiliation and persistent scholarly identifiers provide supporting profile information. [1] [2]

Award suitability should be evaluated using the applicable award criteria and independently verifiable evidence, such as documented research outputs, innovation-related contributions, scholarly records, and relevant professional or institutional achievements. The information available for this page establishes the researcher’s stated field and identifiers but does not provide sufficient quantitative evidence to characterize the scale of research impact.

The recognition is associated with the World Business Global Awards, with the award website serving as the relevant source for information about the event and its recognition framework.

Conclusion

Nana Yang is identified as a researcher affiliated with Nanjing University of Posts and Telecommunications in China, with Innovation Management listed as the subject area. The profile is linked to Scopus Author ID 57215874878 and ORCID 0009-0001-6425-3432. These identifiers provide a basis for scholarly record verification and researcher disambiguation.

In the context of the Best Innovation Award, the available information establishes a clear connection between the researcher’s stated subject area and an innovation-focused recognition category. Detailed assessment of publications, citations, h-index, and specific research achievements requires additional verified bibliographic and documentary evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Nana Yang, Author ID 57215874878. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57215874878
  2. ORCID. (n.d.). Nana Yang, ORCID iD 0009-0001-6425-3432. ORCID.
    https://orcid.org/0009-0001-6425-3432
  3. World Business Global Awards. (n.d.). Business Global Awards.
    https://businessglobalawards.com/

Pere Domingo | Infectious Diseases | Research Excellence Award

Published on by Business Global Awards

Research Excellence Award

Pere Domingo
Hospital de la Santa Creu i Sant Pau, Spain

Pere Domingo
Affiliation Hospital de la Santa Creu i Sant Pau
Country Spain
Scopus ID 7102960369
Documents 738
Citations 24,147
h-index 70
Subject Area Infectious Diseases
Event Business Global Awards
ORCID 0000-0003-1138-5770

Pere Domingo is a researcher in infectious diseases affiliated with Hospital de la Santa Creu i Sant Pau in Spain. His scholarly profile comprises 738 documents, 24,147 citations, and an h-index of 70, indicating a substantial body of indexed research and sustained scholarly visibility. His recent work includes studies addressing cardiovascular prevention in people with HIV, antiretroviral therapy, gut microbiota, hepatitis C epidemiology, and emerging HIV treatment strategies.

Abstract

Pere Domingo’s research profile reflects sustained engagement with contemporary infectious-disease questions, particularly HIV medicine and related comorbidities. Recent publications examine precision cardiovascular prevention following REPRIEVE, emerging integrase strand transfer inhibitors, antiretroviral effects on gut microbiota, and hepatitis C trends among people with HIV in Spain. [1] [2]

Keywords

Infectious Diseases; HIV; Antiretroviral Therapy; Cardiovascular Prevention; Gut Microbiota; Hepatitis C; Precision Medicine; Clinical Research.

Introduction

Contemporary HIV research increasingly considers long-term health outcomes beyond viral suppression, including cardiovascular risk, immune recovery, metabolic effects, and coinfections. Domingo’s recent publication record addresses several of these interconnected areas, placing clinical infectious-disease research within a broader framework of prevention and patient-centered care. [1] [4]

Research Profile

The available bibliometric profile records 738 documents, 24,147 citations, and an h-index of 70 under Scopus author ID 7102960369. These indicators provide a quantitative description of publication activity and citation reach, while individual studies provide additional evidence of the researcher’s involvement in clinically relevant infectious-disease investigations.

Research Contributions

  • Evaluation of cardiovascular prevention strategies for people living with HIV after the REPRIEVE trial.
  • Investigation of emerging antiretroviral therapies and resistance profiles in HIV treatment. [2]
  • Clinical investigation of antiretroviral effects on gut microbiota. [3]
  • Longitudinal assessment of hepatitis C prevalence among people with HIV in Spain. [4]

Publications

Recent publications include Beyond Lipid Lowering: A Narrative Review and Expert Perspective on Precision Cardiovascular Prevention in People with HIV After REPRIEVE, published in Biomolecules on 29 August 2026; Proof-of-Concept Phase 2a Trial of VH4524184 in Clinical Infectious Diseases; and research on dolutegravir, gut microbiota, and hepatitis C epidemiology. [1] [2] [3] [4]

Research Impact

The combination of a substantial indexed publication record and 24,147 citations indicates considerable bibliometric visibility. The thematic range of recent work also demonstrates relevance to prevention, treatment innovation, microbiome research, and infectious-disease epidemiology. Such areas have direct implications for understanding and improving long-term outcomes in people affected by HIV.

Award Suitability

The Research Excellence Award recognizes scholarly achievement supported by research productivity, measurable academic impact, and relevance to an established field. Domingo’s recorded Scopus metrics, specialization in infectious diseases, and recent peer-reviewed publications collectively provide a documented basis for consideration within an academic recognition framework.

Conclusion

Pere Domingo’s research profile reflects sustained scholarly activity in infectious diseases, with particular relevance to HIV treatment, prevention, coinfections, and long-term clinical outcomes. His bibliometric record and recent publications support recognition of a significant contribution to contemporary infectious-disease research.

References

  1. Domingo, P. et al. (2026). Beyond Lipid Lowering: A Narrative Review and Expert Perspective on Precision Cardiovascular Prevention in People with HIV After REPRIEVE. Biomolecules, 16(9), 1254.
    https://doi.org/10.3390/biom16091254
  2. Domingo, P. et al. (2026). Proof-of-Concept Phase 2a Trial of VH4524184: An Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clinical Infectious Diseases.
    https://doi.org/10.1093/cid/ciag357
  3. Domingo, P. et al. (2026). Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. Nature Communications.
    https://doi.org/10.1038/s41467-026-69846-7
  4. Domingo, P. et al. (2026). Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002–2023). Clinical Infectious Diseases.
    https://doi.org/10.1093/cid/ciaf407
  5. Domingo, P. et al. (2026). Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. Nature Communications.
    https://doi.org/10.1038/s41467-026-72458-w
  6. Elsevier. (n.d.). Scopus author details: Pere Domingo, Author ID 7102960369. Scopus.
    https://www.scopus.com/pages/authors/7102960369

Jeong Hyun Kim | Innovation Management | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award

Jeong Hyun Kim
Kangwon National University Hospital, South Korea

Jeong Hyun Kim
Affiliation Kangwon National University Hospital
Country South Korea
Scopus ID 57207436992
Documents 34
Citations 622
h-index 17
Subject Area Innovation Management
Event Business Global Awards

Jeong Hyun Kim is a researcher affiliated with Kangwon National University Hospital whose scholarly record includes work addressing prostate cancer, clinical consensus development, patient-related digital engagement, and regional epidemiological patterns. The available publication record includes peer-reviewed studies published in 2023 and 2025, providing a basis for considering the researcher’s contribution to evidence-oriented innovation in healthcare. [1]

Abstract

This academic recognition profile presents Jeong Hyun Kim in relation to the Innovative Research Award and the field of Innovation Management. The documented research portfolio includes studies on metastatic hormone-sensitive prostate cancer, digital patient-association engagement through the metaverse, and longitudinal prostate cancer risk patterns in a Korean province. These studies illustrate the application of structured evidence generation, multidisciplinary collaboration, digital approaches, and regional health data to contemporary healthcare research. [1] [2]

Keywords

  • Innovation Management
  • Prostate Cancer Research
  • Clinical Consensus
  • Digital Health

Introduction

Innovation in contemporary healthcare increasingly depends on combining clinical evidence with digital tools, collaborative methodologies, and population-level data. Research addressing these dimensions can support more consistent clinical decision-making and improve understanding of changing healthcare environments. Kim’s documented publications reflect this interdisciplinary orientation, particularly within prostate cancer research and digital health communication. [2]

Research Profile

The reported Scopus record lists 34 documents, 622 citations, and an h-index of 17 under Scopus Author ID 57207436992. These indicators provide bibliometric context for the researcher’s scholarly visibility, although publication counts and citation measures should be interpreted alongside research quality, methodological contribution, and field-specific context. [1]

Research Contributions

The 2025 modified Delphi study on metastatic hormone-sensitive prostate cancer contributes to consensus-oriented clinical research in South Korea. A separate 2025 cross-sectional survey examined the use of the metaverse by prostate cancer patient associations during the Blue Ribbon Campaign, representing an application of digital environments to patient engagement. Earlier multicenter research investigated stratified prostate cancer risk trends from 2003 to 2021 using regional training-hospital data. [2] [3]

Publications

  • Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study. Investigative and Clinical Urology, 2025. [2]
  • Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study. Journal of Medical Internet Research, 2025. [3]
  • Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data. Investigative and Clinical Urology, 2023. [4]

Research Impact

The reported citation record indicates that Kim’s publications have received scholarly attention, while the individual studies demonstrate relevance to clinical recommendations, patient-facing digital communication, and regional epidemiology. The combination of these themes is consistent with an innovation-oriented research profile in which established clinical methods are examined alongside emerging digital and data-driven approaches. [1]

Award Suitability

Kim’s documented research is potentially aligned with an Innovative Research Award through its combination of clinical evidence synthesis, digital health exploration, and epidemiological analysis. The portfolio demonstrates multiple approaches to addressing healthcare questions rather than relying on a single methodological perspective. Final award assessment should consider the originality, reproducibility, practical relevance, and independent contribution of the researcher’s work in accordance with the award’s formal evaluation criteria.

Conclusion

Jeong Hyun Kim’s research profile combines prostate cancer clinical research with digital health and population-level investigation. The available bibliometric indicators and selected publications provide a documented basis for scholarly recognition, while the methodological diversity of the work supports consideration within an innovation-focused academic award framework.

References

  1. Elsevier. (n.d.). Scopus author details: Jeong Hyun Kim, Author ID 57207436992. Scopus.
    https://www.scopus.com/pages/authors/57207436992
  2. Joung, J., Jeong, I.-g., Kang, S.-g., et al. (2025). Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study. Investigative and Clinical Urology.
  3. Jo, J., Kim, Y., Ha, Y.-s., et al. (2025). Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study. Journal of Medical Internet Research.
  4. Ko, Y., Kim, B.-h., Kwon, S.-y., et al. (2023). Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data. Investigative and Clinical Urology.
  5. World Health Organization. (2021). Global strategy on digital health 2020–2025. World Health Organization.
  6. National Cancer Institute. (n.d.). Prostate cancer research and clinical information. National Cancer Institute.

Emran Ali | Innovation and Technology Strategy | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award

Emran Ali
Affiliation Alcorn State University
Country United States
Scopus ID 57200798179
Documents 2
Citations 36
h-index 2
Subject Area Innovation and Technology Strategy
Event Business Global Awards
ORCID 0000-0002-1957-4392

Emran Ali
Alcorn State University, United States

Emran Ali is affiliated with Alcorn State University in the United States and is presented for consideration for the Innovative Research Award in recognition of research activity associated with innovation, technology-enabled detection, and applied plant disease research. The available bibliographic profile records 2 documents, 36 citations, and an h-index of 2, providing a quantitative basis for evaluating research visibility and scholarly impact.

Abstract

The Innovative Research Award profile examines Emran Ali’s documented scholarly activity through bibliographic indicators and research outputs relevant to innovation and technology strategy. His publication record includes work concerning rapid molecular detection, plant disease surveillance, pathogen identification, and resistance monitoring. Such applications demonstrate how diagnostic technologies can support timely agricultural decision-making and disease-management research. The profile records 36 citations and an h-index of 2, while the listed publications provide additional context for assessing the practical orientation of the research portfolio.

Keywords

Innovative Research Award; Emran Ali; Alcorn State University; innovation strategy; technology strategy; loop-mediated isothermal amplification; plant disease diagnostics; pathogen detection; agricultural biotechnology; research impact.

Introduction

Modern agricultural research increasingly integrates molecular diagnostics with field-oriented surveillance. Loop-mediated isothermal amplification (LAMP), probe-based assays, and real-time detection approaches are examples of technologies designed to improve the speed and accessibility of pathogen identification. The documented publication portfolio associated with this profile includes research addressing these areas, including detection of Pseudoperonospora cubensis, Clarireedia species, and Phytopythium vexans. [1] [2]

Research Profile

The research profile is characterized by applied diagnostic methodology and plant health surveillance. Bibliographic indicators list 2 documents, 36 citations, and an h-index of 2. The available record is therefore relatively compact but demonstrates measurable scholarly engagement. Research topics represented in the supplied publication record connect laboratory-based detection with agricultural disease management and monitoring.

Research Contributions

  • Development and application of rapid molecular detection approaches for plant pathogens.
  • Investigation of LAMP-based technologies for field-oriented disease detection and surveillance. [3]
  • Contribution to research concerning fungal and oomycete pathogen identification and plant disease management.

Publications

  1. Development of a Novel Pseudoperonospora cubensis-Specific LAMP Assay for Rapid Field Detection and Surveillance of Cucurbit Downy Mildew, Journal of Fungi, 2026.
  2. Identification and Detection of Aflatoxigenic Aspergillus flavus and Aflatoxins: Current Technologies and Future Perspectives, Toxins, 2026.
  3. Probe-Based Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Two Clarireedia spp., the Causal Agent of Dollar Spot of Turfgrass, Plant Disease, 2024.
  4. Real-Time and Rapid Detection of Phytopythium vexans Using Loop-Mediated Isothermal Amplification Assay, Plant Disease, 2023.
  5. First Report of Resistance to Pyraclostrobin in Pseudocercospora spp. from Blackberry (Rubus fruticosus) in Georgia, United States, Plant Health Progress, 2023.

Research Impact

The profile’s 36 citations and h-index of 2 indicate that the documented research has received scholarly attention. The emphasis on rapid detection and surveillance is particularly relevant to agricultural systems in which timely pathogen identification can inform disease-management decisions. The publication record also spans multiple plant health problems, suggesting applicability across different pathogen and crop contexts. [4]

Award Suitability

For the Innovative Research Award, the profile demonstrates several relevant characteristics: application-oriented research, use of modern molecular diagnostic methods, publication in peer-reviewed scientific journals, and measurable citation activity. The work’s emphasis on rapid detection technologies aligns with innovation-focused evaluation criteria concerned with methodological advancement and practical research utility. Award consideration should remain subject to the event’s formal eligibility, verification, and assessment procedures. [5]

Conclusion

Emran Ali’s documented research profile combines measurable scholarly impact with applied investigation into pathogen detection and plant health diagnostics. The supplied publications illustrate the use of molecular and isothermal amplification approaches for rapid disease identification. Together with the reported bibliometric indicators, these activities provide a relevant scholarly basis for consideration under the Innovative Research Award category.

References

  1. Development of a Novel Pseudoperonospora cubensis-Specific LAMP Assay for Rapid Field Detection and Surveillance of Cucurbit Downy Mildew. Journal of Fungi, 2026.
    https://doi.org/10.3390/jof12080626
  2. Identification and Detection of Aflatoxigenic Aspergillus flavus and Aflatoxins: Current Technologies and Future Perspectives. Toxins, 2026.
    https://doi.org/10.3390/toxins18080343
  3. Probe-Based Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Two Clarireedia spp. Plant Disease, 2024.
    https://doi.org/10.1094/PDIS-12-23-2608-RE
  4. Real-Time and Rapid Detection of Phytopythium vexans Using Loop-Mediated Isothermal Amplification Assay. Plant Disease, 2023.
    https://doi.org/10.1094/PDIS-08-22-1944-RE
  5. First Report of Resistance to Pyraclostrobin in Pseudocercospora spp. from Blackberry (Rubus fruticosus) in Georgia, United States. Plant Health Progress, 2023.
    https://doi.org/10.1094/PHP-12-22-0127-BR
  6. Elsevier. (n.d.). Scopus author details: Emran Ali, Author ID 57200798179. Scopus.
    https://www.scopus.com/pages/authors/57200798179
  7. ORCID. (n.d.). Emran Ali, ORCID iD 0000-0002-1957-4392.
    https://orcid.org/0000-0002-1957-4392

Mohammadreza Hafezi | Medizin-Chirurgie | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award


Mohammadreza Hafezi
Heidelberg University, Germany

Mohammadreza Hafezi
Affiliation Heidelberg University
Country Germany
Scopus ID 37103996600
Documents 36
Citations 1,664
h-index 19
Subject Area Medizin-Chirurgie
Event Business Global Awards

Mohammadreza Hafezi is a researcher affiliated with Heidelberg University whose indexed scholarly work includes studies in surgical medicine, transplantation-related research, vascular reconstruction, and experimental diagnostic imaging. His publication record includes collaborative investigations addressing clinically relevant and technically demanding questions, providing a basis for consideration within an Innovative Research Award framework. The available bibliometric information records 36 documents, 1,664 citations, and an h-index of 19.

Abstract

Mohammadreza Hafezi’s documented research activity reflects interdisciplinary surgical investigation conducted within the Heidelberg academic environment. His publications address renal artery reconstruction, kidney autotransplantation, experimental elastography, and modulation of hepatic blood flow following extensive liver resection. These studies combine clinical, systematic-review, and experimental approaches and demonstrate engagement with methodological questions relevant to modern surgical practice. [1] [2]

Keywords

Innovative research; transplantation surgery; renal artery aneurysm; kidney autotransplantation; hepatic surgery; portocaval shunt; elastography; surgical innovation; experimental medicine; Heidelberg University.

Introduction

Innovation in surgical research frequently emerges through the integration of operative techniques, imaging methodologies, vascular management, and evidence synthesis. Hafezi’s indexed publications illustrate this multidisciplinary orientation. His collaborative work has examined both experimental models and clinical evidence, with an emphasis on technically complex problems in transplantation and vascular surgery. [2] [3]

Research Profile

The research profile represented by the supplied publication record spans surgical reconstruction, transplantation, experimental organ models, and quantitative assessment of physiological changes. The work is characterized by collaboration across surgical and diagnostic disciplines and by the use of models that can inform understanding of complex clinical procedures.

Research Contributions

  • Contribution to research on kidney autotransplantation as a reconstructive option for selected renal artery aneurysms. [2]
  • Participation in experimental research investigating portocaval shunting and transhepatic flow after extended hepatectomy. [1]
  • Contribution to imaging research using ARFI shear-wave elastography in an experimental porcine kidney model. [3]

Publications

Among the supplied publications, Hafezi is a co-author of the 2022 Scientific Reports article examining portocaval shunting after extended hepatectomy, the 2022 systematic review on renal artery repair with kidney autotransplantation, and the 2018 study of ARFI shear-wave elastography in an ex vivo porcine kidney model. [1] [2] [3]

Research Impact

The supplied bibliometric record reports 1,664 citations and an h-index of 19 across 36 documents. These indicators provide quantitative evidence of scholarly visibility, although citation metrics should be interpreted alongside publication quality, methodological contribution, collaboration, and relevance to clinical or scientific practice. The cited publications demonstrate engagement with research questions extending from experimental models to systematic clinical evidence. [2]

Award Suitability

For the Innovative Research Award associated with Business Global Awards, Hafezi’s profile can be assessed on the basis of documented publication activity, interdisciplinary collaboration, methodological diversity, and measurable scholarly impact. The evidence supports consideration of research innovation in surgical and translational contexts without implying that bibliometric indicators alone establish award eligibility.

Conclusion

Mohammadreza Hafezi’s research record reflects sustained participation in collaborative investigations across transplantation, vascular surgery, hepatic surgery, and diagnostic imaging. The combination of 36 documents, 1,664 citations, and an h-index of 19, together with the documented studies, provides a substantive scholarly profile for evaluation within an academic recognition framework.

References

  1. Golriz, M., Majlesara, A., Khajeh, E., et al. (2022). Portocaval shunt can optimize transhepatic flow following extended hepatectomy: a short-term study in a porcine model. Scientific Reports, 12, 1668.
    https://doi.org/10.1038/s41598-022-05327-3
  2. Ramouz, A., Hafezi, M., Ali-Hasan-Al-Saegh, S., et al. (2022). Renal Artery Repair with Kidney Autotransplantation for Renal Artery Aneurysms. European Journal of Vascular and Endovascular Surgery, 63(5), 732–742.
    https://doi.org/10.1016/j.ejvs.2022.01.015
  3. Muttray, J., Mehrabi, A., Hafezi, M., et al. (2018). ARFI shear-wave elastography with simulation of acute urinary tract obstruction in an ex vivo porcine kidney model. Diagnostic and Interventional Radiology, 24(5), 308–315.
    https://doi.org/10.5152/dir.2018.17353
  4. Elsevier. (n.d.). Scopus author details: Mohammadreza Hafezi, Author ID 37103996600. Scopus.
    https://www.scopus.com/pages/authors/37103996600
  5. Heidelberg University. (n.d.). University research and academic information.
  6. Business Global Awards. (n.d.). Official award website.
    businessglobalawards.com

Sampson Mamphweli | Innovation and Technology Strategy | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award

Sampson Mamphweli
South African National Energy Development Institute, South Africa

Sampson Mamphweli
Affiliation South African National Energy Development Institute
Country South Africa
Scopus ID 55619587300
Documents 40
Citations 2,674
h-index 16
Subject Area Innovation and Technology Strategy
Event Business Global Awards
ORCID 0000-0002-1845-0347

Sampson Mamphweli is a South African researcher whose scholarly work addresses renewable energy, biomass conversion, solar-energy technologies, materials, and sustainable energy systems. His research record reflects an interdisciplinary approach connecting engineering research with practical energy-development challenges. Bibliographic indicators supplied for this profile report 40 documents, 2,674 citations, and an h-index of 16, providing a quantitative basis for considering his research activity and influence. [1]

Abstract

This academic recognition profile presents the research record of Sampson Mamphweli in the context of the Innovative Research Award. His documented publications include investigations of biomass gasification, torrefaction, solar-module degradation, photocatalytic materials, and characterization of biomass resources. These studies demonstrate engagement with energy conversion, sustainable technologies, and applied materials research. [2]

Keywords

Innovation; renewable energy; biomass gasification; sustainable technology; solar energy; photocatalysis; energy conversion; research strategy.

Introduction

Research in sustainable energy requires integration of scientific investigation, engineering design, resource assessment, and technological implementation. Mamphweli’s publication record reflects this multidisciplinary orientation, particularly through studies focused on biomass-derived fuels and energy systems. [3]

Research Profile

The supplied bibliometric profile identifies 40 documents, 2,674 citations, and an h-index of 16. His stated subject area, Innovation and Technology Strategy, is consistent with a research portfolio that combines technological development with applications in sustainable energy. [1]

Research Contributions

  • Analysis of carbon particles recovered from downdraft biomass gasification systems. [4]
  • Investigation of torrefaction and its influence on biomass gasification efficiency. [5]
  • Research concerning solar-module encapsulation degradation and photovoltaic materials. [6]
  • Characterization of biomass resources for energy-production applications and photocatalytic materials. [7]

Publications

Selected publications supplied for this profile include work on carbon particles from biomass gasification, photovoltaic encapsulation degradation, torrefaction of sugarcane bagasse, corn-cob characterization, and silver/carbon codoped titanium dioxide photocatalysts. [7]

Research Impact

The reported citation count and h-index indicate sustained scholarly visibility. The research themes also address practical questions in renewable energy and materials science, areas relevant to technological innovation and sustainable development. Bibliometric indicators should, however, be interpreted alongside publication quality, originality, methodological rigor, and field context.

Award Suitability

Based on the supplied academic record, Mamphweli demonstrates characteristics relevant to an Innovative Research Award, including interdisciplinary research activity, documented scholarly output, measurable citation impact, and sustained engagement with renewable-energy technologies. The assessment is based on the information provided and does not constitute an independent peer-review determination.

Conclusion

Sampson Mamphweli’s research profile combines renewable-energy engineering, biomass utilization, photovoltaic technology, and materials research. His reported bibliometric indicators and selected publications provide a substantive academic basis for recognition within an innovation-focused research context.

References

  1. Elsevier. (n.d.). Scopus author details: Sampson Mamphweli, Author ID 55619587300. Scopus.
    https://www.scopus.com/pages/authors/55619587300
  2. Mamphweli, S. et al. (2017). Selected research on biomass, solar energy and sustainable energy technologies. Publication record supplied for academic profile.
  3. Anukam, A., Mamphweli, S., Reddy, P., Meyer, E., & Okoh, O. (2017). Influence of torrefaction on the conversion efficiency of the gasification process of sugarcane bagasse. Bioengineering, 4(22), 1–23.
  4. Nwokolo, N., Mamphweli, S., & Makaka, G. (2017). Analytical and thermal evaluation of carbon particles recovered at the cyclone of a downdraft biomass gasification system. Sustainability, 9(4), 645. https://doi.org/10.3390/su9040645
  5. Anukam, A., Goso, B., Okoh, O., & Mamphweli, S. (2017). Studies on characterization of corn cob for application in a gasification process for energy production. Journal of Chemistry, 1–9.
  6. Osayemwenre, G. O., Meyer, E. L., Taziwa, R. T., & Mamphweli, S. (2017). Photo-thermal degradation analysis of single-junction amorphous solar module’s EVA encapsulation. Journal of Ovonic Research, 13, 225–232.
  7. Nyamukamba, P., Tichagwa, L., Mamphweli, S., & Petrik, L. (2017). Silver/Carbon Codoped Titanium Dioxide Photocatalyst for Improved Dye Degradation under Visible Light. International Journal of Photoenergy, 2017, Article ID 3079276, 9 pages.
    https://doi.org/10.1155/2017/3079276

Juliet Haarbauer-Krupa | Innovation Strategy | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award

Juliet Haarbauer-Krupa
Affiliation Emory University School of Medicine
Country United States
Scopus ID 56716250700
Documents 77
Citations 2,528
h-index 26
Subject Area Innovation Strategy
Event Business Global Awards
ORCID 0000-0002-2013-6453

Juliet Haarbauer-Krupa
Emory University School of Medicine, United States

Juliet Haarbauer-Krupa is a researcher affiliated with Emory University School of Medicine in the United States whose scholarly work addresses pediatric traumatic brain injury, rehabilitation, transition to adulthood, and related health and service outcomes. Her documented research profile comprises 77 documents, 2,528 citations, and an h-index of 26, providing a bibliometric basis for consideration within an academic recognition framework.

Abstract

This academic recognition profile presents the research record of Juliet Haarbauer-Krupa, emphasizing scholarship concerning traumatic and acquired brain injury among children, adolescents, and young adults. Recent publications address transition to adulthood, early childhood traumatic brain injury, communication-related care, and independence outcomes. [1] [2] The profile is considered in relation to research productivity, scholarly visibility, thematic relevance, and documented publication activity.

Keywords

Innovation Strategy; Traumatic Brain Injury; Pediatric Neurology; Rehabilitation; Adolescent Health; Research Impact; Clinical Research; Transition to Adulthood.

Introduction

Research on pediatric brain injury requires interdisciplinary approaches connecting clinical care, rehabilitation, communication, health services, and long-term independence. Haarbauer-Krupa’s recent publication record reflects this multidisciplinary perspective, including studies examining developmental transitions and health-service associations. [2] Such work contributes evidence relevant to improving understanding of outcomes across childhood and young adulthood.

Research Profile

The available bibliometric profile records 77 documents, 2,528 citations, and an h-index of 26. Her research interests represented in the supplied publication record include acquired and traumatic brain injury, pediatric populations, transition to adulthood, speech-language considerations, career development, and independence. [3] These themes demonstrate continuity across clinical and applied research questions.

Research Contributions

Recent work examines how children with acquired brain injury navigate transition toward adulthood, including clinical lessons relevant to independence and longer-term support. [1] Additional research considers traumatic brain injury among children aged 0–5 years and associations with selected health conditions and services. [2] Related scholarship highlights the role of speech-language pathologists in pediatric traumatic brain injury care. [3]

Publications

  • Transition to Adulthood for Children Who Experienced Acquired Brain Injury: Lessons Learned from a Clinical Program for Children and Adolescents, Children, 2026. [1]
  • Traumatic Brain Injury in Children Ages 0-5 Years and Associations with Select Health Conditions and Services, Pediatric Neurology, 2026. [2]
  • Pediatric Traumatic Brain Injury: Speech-Language Pathologists Must Have a Seat at the Table, American Journal of Speech-Language Pathology, 2026. [3]
  • Understanding How Mild Traumatic Brain Injury Impacts the Career and Independence of Young Adults, Neurotrauma Reports, 2025. [5]

Research Impact

The supplied citation profile indicates substantial scholarly visibility, with 2,528 citations and an h-index of 26. The publication record further indicates continuing engagement with clinically relevant questions affecting pediatric and young-adult populations. [6] These indicators provide measurable evidence of research reach while the subject matter demonstrates practical relevance to healthcare and rehabilitation research.

Award Suitability

For the Innovative Research Award, the profile presents a combination of sustained scholarly productivity, citation-based research visibility, and contemporary work addressing complex clinical and developmental questions. The relevance of these contributions to innovation strategy may be considered through the application of research evidence to clinical programs, multidisciplinary practice, and improved understanding of long-term outcomes.

Conclusion

Juliet Haarbauer-Krupa’s documented research profile reflects an established body of scholarly work in pediatric traumatic brain injury and related areas. Her publication activity, citation record, and interdisciplinary research themes provide a substantive basis for academic recognition under an Innovative Research Award framework.

References

  1. Haarbauer-Krupa, J. et al. (2026). Transition to Adulthood for Children Who Experienced Acquired Brain Injury: Lessons Learned from a Clinical Program for Children and Adolescents. Children, 13(8), 1086.
    https://doi.org/10.3390/children13081086
  2. Haarbauer-Krupa, J. et al. (2026). Traumatic Brain Injury in Children Ages 0-5 Years and Associations with Select Health Conditions and Services. Pediatric Neurology.
    https://doi.org/10.1016/j.pediatrneurol.2026.08.001
  3. Haarbauer-Krupa, J. et al. (2026). Pediatric Traumatic Brain Injury: Speech-Language Pathologists Must Have a Seat at the Table. American Journal of Speech-Language Pathology.
    https://doi.org/10.1044/2026_AJSLP-26-00120
  4. Haarbauer-Krupa, J. et al. (2026). Traumatic Brain Injury in Children Ages 0-5 Years and Associations with Select Health Conditions and Services. SSRN preprint.
    https://doi.org/10.2139/ssrn.6468944
  5. Haarbauer-Krupa, J. et al. (2025). Understanding How Mild Traumatic Brain Injury Impacts the Career and Independence of Young Adults. Neurotrauma Reports.
    https://doi.org/10.1177/08977151251362109
  6. Elsevier. (n.d.). Scopus author details: Juliet Haarbauer-Krupa, Author ID 56716250700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56716250700

Mahmoud Elmarzouky | Corporate Social Responsibility and Sustainability | Research Excellence Award

Published on by Business Global Awards

Research Excellence Award

Mahmoud Elmarzouky
University of St Andrews, United Kingdom

Mahmoud Elmarzouky
Affiliation University of St Andrews
Country United Kingdom
Scopus ID 57222869551
Documents 45
Citations 1,818
h-index 21
Subject Area Corporate Social Responsibility and Sustainability
Event Business Global Awards
ORCID 0000-0001-9867-6057

Mahmoud Elmarzouky is a researcher affiliated with the University of St Andrews whose reported scholarly profile encompasses corporate social responsibility, sustainability, accounting, governance, taxation, digital disclosure, and emerging technologies. The profile records 45 documents, 1,818 citations, and an h-index of 21. [1] The research record includes recent publications addressing climate-impact disclosure, human-rights risks, tax aggressiveness, algorithmic trading, and artificial intelligence-enabled sustainability strategies. [2][3]

Abstract

This article presents an academic recognition profile for Mahmoud Elmarzouky, emphasizing documented research activity and recent scholarly outputs. His publication portfolio demonstrates an interdisciplinary focus connecting sustainability, corporate governance, accounting, taxation, disclosure, and technology. Recent work published in 2026 addresses board gender diversity and climate-impact disclosure, multilevel governance of human-rights risks, digital disclosure complexity, explainable algorithmic trading, and artificial intelligence-driven sustainability strategies. [2][3][4]

Keywords

Corporate social responsibility; sustainability; ESG; corporate governance; climate disclosure; human rights; accounting; taxation; artificial intelligence; digital disclosure.

Introduction

Research on sustainability and responsible corporate conduct increasingly intersects with accounting information, governance structures, digital technologies, and regulatory accountability. Within this context, Elmarzouky’s recent work examines how organizations communicate environmental and social effects while managing information, tax, and technological risks. These themes position the research profile at the intersection of sustainability scholarship and contemporary accounting and governance questions. [2][3]

Research Profile

The available profile reports 45 documents, 1,818 citations, and an h-index of 21. [1] The stated subject area, Corporate Social Responsibility and Sustainability, is complemented by research addressing accounting information systems, taxation, corporate disclosure, governance, and sustainable innovation.

Research Contributions

  • Climate-impact disclosure is examined in relation to board gender diversity and corporate reporting quality. [2]
  • Sustainability-related human-rights risks are considered through multilevel governance and institutional accountability. [3]
  • Digital disclosure complexity is connected with tax aggressiveness using US XBRL filings. [4]
  • Emerging technology research addresses explainable algorithmic trading and AI-powered innovation for ESG and sustainable ecosystems. [5][6]

Publications

Selected 2026 publications include Board Gender Diversity and the Quality of Corporate Climate Impact Disclosure: UK Evidence (4 August 2026), Managing Sustainability-Related Human Rights Risks (9 June 2026), Digital disclosure complexity and tax aggressiveness (1 June 2026), Explainable algorithmic trading with embedded audit and tax trails (17 March 2026), and Artificial Intelligence-Powered Innovation Strategies for ESG Impact and Sustainable Ecosystems (5 March 2026). [2][3][4][5][6]

Research Impact

The reported citation count and h-index indicate measurable scholarly uptake, while the breadth of recent publications demonstrates engagement with current debates in sustainability, disclosure, governance, and accounting technology. [1] The evidence supports consideration of the researcher within an academic recognition context, subject to the award body’s independent assessment criteria.

Award Suitability

For a research excellence recognition associated with Business Global Awards, the profile presents several relevant indicators: a defined sustainability-oriented research area, established bibliometric activity, and recent peer-reviewed publications in internationally recognized journals. [1] Suitability should nevertheless be determined through transparent evaluation of publication quality, originality, scholarly contribution, and the specific eligibility requirements of the award.

Conclusion

Mahmoud Elmarzouky’s documented research profile combines sustainability and corporate responsibility with accounting, governance, taxation, disclosure, and emerging digital technologies. The reported bibliometric indicators and recent 2026 publications provide a substantive basis for academic recognition, while maintaining an evidence-based distinction between documented outputs and broader award judgments.

References

  1. Elsevier. (n.d.). Scopus author details: Mahmoud Elmarzouky, Author ID 57222869551. Scopus.
    https://www.scopus.com/pages/authors/57222869551
  2. Elmarzouky, M. (2026). Board Gender Diversity and the Quality of Corporate Climate Impact Disclosure: UK Evidence. Business Strategy and the Environment.
    DOI: 10.1002/bse.71356
  3. Elmarzouky, M. (2026). Managing Sustainability-Related Human Rights Risks: The Role of Multilevel Governance and Institutional Accountability. Business Strategy and the Environment.
    DOI: 10.1002/bse.71124
  4. Elmarzouky, M. (2026). Digital disclosure complexity and tax aggressiveness: insights from US XBRL filings. Journal of Accounting Literature.
    DOI: 10.1108/JAL-05-2025-0227
  5. Elmarzouky, M. (2026). Explainable algorithmic trading with embedded audit and tax trails. International Journal of Accounting and Information Management.
    DOI: 10.1108/IJAIM-10-2025-0351
  6. Elmarzouky, M. (2026). Artificial Intelligence-Powered Innovation Strategies for ESG Impact and Sustainable Ecosystems: A Natural-Resource-Based and Environmental-Legitimacy Perspective. Business Strategy and the Environment.
    DOI: 10.1002/bse.70654

Yazan Barqawi | Innovation and Technology Strategy | Innovative Research Award

Published on by Business Global Awards

Innovative Research Award

Yazan Barqawi
Astra Zeneca, United States

Yazan Barqawi
Affiliation Astra Zeneca
Country United States
Scopus ID 56716382800
Documents 8
Citations 61
h-index 4
Subject Area Innovation and Technology Strategy
Event Business Global Awards
ORCID 0000-0002-3045-6813

Yazan Barqawi is a researcher affiliated with Astra Zeneca in the United States whose scholarly record encompasses research at the intersection of healthcare, evidence-based intervention, treatment patterns, and innovation-oriented strategy. The available publication record includes peer-reviewed and conference contributions addressing digital health education in heart failure and real-world treatment patterns in hematological malignancies. These outputs provide a basis for considering the researcher within an innovation and technology strategy context, particularly where evidence generation supports the evaluation and adoption of healthcare interventions.

Abstract

This academic recognition profile presents the research record of Yazan Barqawi in relation to the Innovative Research Award. The documented portfolio includes research on digital health interventions incorporating educational components for patients with heart failure, as well as real-world treatment patterns and outcomes in hematological diseases. A systematic review and meta-analysis published in Healthcare in August 2026 examined the clinical impact of digital health interventions with educational components for patients with heart failure. [1] A related preprint addressing digital health education for patients with heart failure was published in December 2025. [2] Additional conference research examined first- and second-line treatment patterns in B-cell acute lymphoblastic leukemia and real-world treatment patterns and outcomes among treatment-naive patients with mantle cell lymphoma. [3] [4]

Keywords

Keywords: Innovative Research Award; digital health; health education; heart failure; systematic review; meta-analysis; clinical impact; real-world evidence; hematology; acute lymphoblastic leukemia; mantle cell lymphoma; treatment patterns; healthcare innovation; technology strategy; evidence-based research.

Introduction

Digital transformation in healthcare has expanded the role of technology-supported interventions in patient education, clinical monitoring, communication, and self-management. Systematic reviews and meta-analyses are particularly important in this environment because they synthesize available evidence and can clarify the extent to which digital interventions are associated with measurable clinical outcomes. The publication on the clinical impact of digital health interventions with educational components for patients with heart failure reflects this evidence-synthesis approach. [1]

The research portfolio also includes studies based on real-world treatment data. Such research is relevant to healthcare strategy because treatment patterns observed in routine practice may complement evidence generated through controlled research settings. The documented work on B-cell acute lymphoblastic leukemia and mantle cell lymphoma illustrates the application of observational and health-data approaches to understanding treatment practices and outcomes. [3] [4]

Research Profile

Yazan Barqawi’s indexed research profile contains 8 documents, 61 citations, and an h-index of 4 according to the supplied researcher information. The portfolio spans journal publication, preprint dissemination, and conference research. Its subject-area framing is Innovation and Technology Strategy, while the documented studies are strongly situated within healthcare research and evidence-based evaluation.

The available record indicates several complementary research characteristics:

  • Application of systematic review and meta-analysis methods to evaluate digital health interventions.
  • Investigation of educational components within digital health interventions for patients with heart failure.
  • Analysis of treatment patterns in hematological malignancies using real-world evidence.

Research Contributions

A principal contribution in the documented portfolio is the systematic evaluation of digital health interventions containing educational components for patients with heart failure. The associated article, published in Healthcare, uses systematic review and meta-analysis methodology to investigate clinical impact. [1] This type of research is relevant to digital healthcare strategy because it consolidates findings from multiple studies rather than relying on a single intervention or clinical setting.

The corresponding preprint, published in December 2025, provides an earlier dissemination of research focused specifically on digital health education for patients with heart failure. [2] The relationship between preprint and subsequent journal publication illustrates a research-development pathway from preliminary dissemination toward formal peer-reviewed publication.

Publications

The supplied publication record includes the following documented outputs:

  1. Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis.[1]
  2. Clinical Impact of Digital Health Education for Patients with Heart Failure: A Systematic Review and Meta-Analysis (Preprint).[2]
  3. FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS.[3]
  4. 269 | REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH TREATMENT-NAIVE MANTLE CELL LYMPHOMA IN THE UK, SWEDEN, AND FRANCE.

Research Impact

The available bibliometric profile records 61 citations and an h-index of 4 across 8 documents. These indicators provide quantitative information concerning the visibility and citation activity of the indexed record. They should be interpreted alongside publication quality, methodological rigor, disciplinary context, collaboration, and the specific contribution of individual studies.

The subject matter of the documented research has potential relevance to healthcare innovation through two complementary evidence pathways. Digital health research can contribute to understanding the effectiveness and clinical implications of technology-supported education, while real-world treatment research can provide evidence concerning how therapies are used and outcomes observed in routine practice. The systematic review and meta-analysis published in Healthcare is particularly relevant to evidence synthesis in digital health. [1]

The international scope of the hematological oncology research, including data or observations relating to the United Kingdom, Sweden, and France, also demonstrates attention to cross-country real-world treatment patterns. [4] Such comparative perspectives can be useful when examining variation in treatment practices and the transferability of evidence across healthcare environments.

Award Suitability

The documented record provides several areas of alignment with the Innovative Research Award. The strongest alignment is the combination of digital health research, evidence synthesis, patient education, and real-world healthcare analytics. These themes correspond to contemporary approaches in which technological innovation is assessed not only by novelty but also by evidence concerning clinical relevance and practical application.

The award suitability assessment can be summarized through the following dimensions:

  • Research contribution: The portfolio contains peer-reviewed and conference research addressing clinically relevant healthcare questions.
  • Innovation relevance: Digital health education and technology-supported interventions represent contemporary areas of healthcare innovation.

Conclusion

Yazan Barqawi’s documented research portfolio represents an applied evidence-oriented contribution spanning digital health, patient education, systematic evidence synthesis, and real-world treatment research. The publication record includes a 2026 systematic review and meta-analysis in Healthcare, a related preprint, and conference research addressing treatment patterns in hematological malignancies. [1] [2] [3] [4]

References

  1. Healthcare. (2026). Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Publication date: 9 August 2026. DOI: 10.3390/healthcare14162460.
    https://doi.org/10.3390/healthcare14162460
  2. JMIR Preprints. (2025). Clinical Impact of Digital Health Education for Patients with Heart Failure: A Systematic Review and Meta-Analysis (Preprint). Publication date: 22 December 2025. DOI: 10.2196/preprints.90163.
    https://doi.org/10.2196/preprints.90163
  3. European Hematology Association. (2025). FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS. EHA 2025 Congress, published 12 June 2025.
    https://library.ehaweb.org/eha/2025/eha2025-congress/4161446/nikesh.shah.first-line.281l29.and.second-line.282l29.treatment.patterns.in.htm
  4. Wiley. (2025). 269 | REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH TREATMENT-NAIVE MANTLE CELL LYMPHOMA IN THE UK, SWEDEN, AND FRANCE. Hematological Oncology, June 2025. DOI: 10.1002/hon.70094_269.
    https://doi.org/10.1002/hon.70094_269
  5. Elsevier. (n.d.). Scopus author details: Yazan Barqawi, Author ID 56716382800. Scopus.
    https://www.scopus.com/pages/authors/56716382800
  6. ORCID. (n.d.). ORCID record for Yazan Barqawi.
    https://orcid.org/0000-0002-3045-6813